1343 related articles for article (PubMed ID: 14518722)
1. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
2. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
3. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
Hekmat S; Mohraz M; Vahabpour R; Jam S; Bahramali G; Banifazl M; Aghakhani A; Eslamifar A; Mahboudi F; Edalat R; Ramezani A
J Med Virol; 2008 Nov; 80(11):1941-6. PubMed ID: 18814233
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.
Alcalde R; Nishiya A; Casseb J; Inocêncio L; Fonseca LA; Duarte AJ
Virus Res; 2010 Aug; 151(2):148-52. PubMed ID: 20420864
[TBL] [Abstract][Full Text] [Related]
5. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
Li C; Collini P; Danso K; Owusu-Ofori S; Dompreh A; Candotti D; Opare-Sem O; Allain JP
AIDS; 2006 Feb; 20(3):379-86. PubMed ID: 16439871
[TBL] [Abstract][Full Text] [Related]
6. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
[TBL] [Abstract][Full Text] [Related]
7. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; Morsica G; Pizzaferri P; Ladisa N; Sighinolfi L; Chiodera A; Solmone M; Lalle E; Ippolito G; Monforte Ad; ;
Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of circulating natural type 1 interferon-producing cells in HIV/GBV-C and HIV/HCV coinfected patients: a preliminary study.
Haji Molla Hoseini M; Pourfathollah AA; Mohraz M; Soheili Z; Amini S; Aghaiepour M; Samiee S; Nikoogoftar M; Meshkani R
Arch Med Res; 2007 Nov; 38(8):868-75. PubMed ID: 17923269
[TBL] [Abstract][Full Text] [Related]
9. GB virus C genotype determination in GB virus-C/HIV co-infected individuals.
Muerhoff AS; Tillmann HL; Manns MP; Dawson GJ; Desai SM
J Med Virol; 2003 May; 70(1):141-9. PubMed ID: 12629656
[TBL] [Abstract][Full Text] [Related]
10. Infection with GB virus C and reduced mortality among HIV-infected patients.
Tillmann HL; Heiken H; Knapik-Botor A; Heringlake S; Ockenga J; Wilber JC; Goergen B; Detmer J; McMorrow M; Stoll M; Schmidt RE; Manns MP
N Engl J Med; 2001 Sep; 345(10):715-24. PubMed ID: 11547740
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
[TBL] [Abstract][Full Text] [Related]
12. [GB virus C: lack of association with transaminases levels, CD4 and HIV viral load in aids patients].
López Calvo S; Vela A; Castro A; Cid A; Aguilera A; Vega P; Hermida M; Regueiro BJ; Pedreira JD
An Med Interna; 2003 Apr; 20(4):175-8. PubMed ID: 12768829
[TBL] [Abstract][Full Text] [Related]
13. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
[TBL] [Abstract][Full Text] [Related]
14. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
[TBL] [Abstract][Full Text] [Related]
15. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
16. Persistent GB virus C infection and survival in HIV-infected men.
Williams CF; Klinzman D; Yamashita TE; Xiang J; Polgreen PM; Rinaldo C; Liu C; Phair J; Margolick JB; Zdunek D; Hess G; Stapleton JT
N Engl J Med; 2004 Mar; 350(10):981-90. PubMed ID: 14999110
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
18. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
Rodriguez B; Woolley I; Lederman MM; Zdunek D; Hess G; Valdez H
J Infect Dis; 2003 Feb; 187(3):504-7. PubMed ID: 12552436
[TBL] [Abstract][Full Text] [Related]
19. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study.
Van der Bij AK; Kloosterboer N; Prins M; Boeser-Nunnink B; Geskus RB; Lange JM; Coutinho RA; Schuitemaker H
J Infect Dis; 2005 Mar; 191(5):678-85. PubMed ID: 15688280
[TBL] [Abstract][Full Text] [Related]
20. A new genotype 2 subcluster identified among GBV-C strains circulating in the Lisbon metropolitan area of Portugal.
Branco C; Esteves A; Piedade J; Parreira R
J Med Virol; 2010 Mar; 82(3):452-9. PubMed ID: 20087931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]